Citius Oncology (CTOR) Change in Accrued Expenses (2023 - 2026)
Citius Oncology (CTOR) reported Change in Accrued Expenses of $16,047 for fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with -$263,614 a year earlier and down 99.9% from the prior quarter.
Powered by 
Analysis
Citius Oncology (CTOR) Change in Accrued Expenses (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Citius Oncology's Change in Accrued Expenses came in at $15.62 million, up 84.7% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $4.09 million.
- Change in Accrued Expenses has a three-year compound annual growth rate of 440.0% (FY2022 to FY2025).
- By fiscal year, Change in Accrued Expenses came in at -$259,071 in FY2024, $349,051 in FY2023 and $25,988 in FY2022.
- Five-year quarterly Change in Accrued Expenses spans a low of -$4.37 million in fiscal Q4 2025 and a high of $19.54 million in fiscal Q2 2026.
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $19.54 million (Q2 2026), $425,792 (Q1 2026) and -$4.37 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accrued Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 983.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -87.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 756.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Citius Oncology | 60.42 Mn | 30.00 Mn | 1.00 Mn | 16,047.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16,047.00 |
| Mar 31, 2026 | 19.54 Mn |
| Dec 31, 2025 | 425,792.00 |
| Sep 30, 2025 | -4.37 Mn |
| Jun 30, 2025 | -263,614.00 |
| Mar 31, 2025 | 2.49 Mn |
| Dec 31, 2024 | 6.23 Mn |
| Jun 30, 2024 | -2,487.00 |
| Mar 31, 2024 | 112,349.00 |
| Dec 31, 2023 | -199,155.00 |
| Jun 30, 2023 | 66,120.00 |
| Mar 31, 2023 | 15,944.00 |
API Access
Citius Oncology Change in Accrued Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=CTOR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "CTOR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=CTOR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();